Lenvatinib-induced pemphigus erythematosus in hepatocellular carcinoma: a unique case report

Adjuvant lenvatinib in combination with transarterial chemoembolization (TACE) has demonstrated prolonged disease-free survival in hepatocellular carcinoma patients at high risk of recurrence post-resection. Here, we present the case of a 68-year-old woman who developed serious side effects includin...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Xiaoqing Li, Suhua Ma, Qing She, Zirong Liu, Yanan Liu, Yanjing Kuang, Xiaozhun Huang, Zhengyin Zhan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-03-01
Subjects:	lenvatinib hepatocellular carcinoma pemphigus adverse drug reaction case report
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1505596/full